A critical breakthrough in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in many types of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research